Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma

Background: The benefits of hepatitis C virus (HCV)eradication for hepatocellular carcinoma (HCC) patients in Barcelona Clinic Liver Cancer (BCLC) stage B/C remain uncertain. Methods: In this hospital-based cohort study, all HCV-infected patients with BCLC stage B/C HCC during the period January 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Shou-Wu, Chen, Li-Shu, Yang, Sheng-Shun, Huang, Yi-Hsiang, Lee, Teng-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695594/
https://www.ncbi.nlm.nih.gov/pubmed/36366415
http://dx.doi.org/10.3390/v14112316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695594/
https://www.ncbi.nlm.nih.gov/pubmed/36366415
http://dx.doi.org/10.3390/v14112316

Ejemplares similares